Skip to main content
SpringerLink
Log in

Reproducibility over time of the urinary diclofenac/4′-OH diclofenac ratio among differentCYP2C9 genotypes

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Diclofenac has been used for the evaluation of CYP2C9 activityin vitro as well asin vivo with varying results. The present study was aimed at evaluating the reproducibility of the urinary diclofenac/4′-OH diclofenac ratio among differentCYP2C9 genotypes in healthy volunteers. The study ofCYP2C9 genotypes in the family of aCYP2C9*3/*3 subject is also reported. The urinary diclofenac/4′-OH diclofenac ratio was determined on two occasions within a period of 9–12 months, and was found to be correlated (r=0.83,p<0.05). The mean (±SD) of diclofenac/4′-OH diclofenac ratio was 1.5 times higher among subjects carryingCYP2C9*3 allele (CYP2C9*1/*3 andCYP2C9*2/*3 genotypes) (0.91±0.28), compared toCYP2C9*1/*1 subjects (0.60±0.11). The results show that the urinary diclofenac/4′-OH diclofenac ratio might be used to study CYP2C9 in humans. The data agree with previous studies showing that theCYP2C9*3 allelic variant seems to cause a decreased CYP2C9 hydroxylation capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Xie H.G., Prasad H.C., Kim R.B., Stein C.M. (2002):CYP2C9 allelic variants: ethnic distribution and functional significance. Adv. Drug. Deliv. Rev., 54, 1257–1270.

    Article  CAS  PubMed  Google Scholar 

  2. Miners J.O., Birkett D.J. (1998): Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br. J. Clin. Pharmacol., 45, 525–538.

    Article  CAS  PubMed  Google Scholar 

  3. Lee C.R., Goldstein J.A., Pieper J. (2002): Cytochrome P4502C9 polymorphisms: a comprehensive review of the in vitro and human data. Pharmacogenetics, 12, 251–263.

    Article  CAS  PubMed  Google Scholar 

  4. Shimamoto J., Ieiri I., Urae A., et al. (2000): Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the singleCYP2C9*3 allele. Eur. J. Clin. Pharmacol., 56, 65–68.

    Article  CAS  PubMed  Google Scholar 

  5. Morin S., Loriot M.A., Poirier J.M., et al. (2001): Is diclofenac a valuable CYP2C9 probe in humans? Eur. J. Clin. Pharmacol., 56, 793–797.

    Article  CAS  PubMed  Google Scholar 

  6. Yasar Ü., Eliasson E., Forslund-Bergengren C., et al. (2001): The role ofCYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro. Eur. J. Clin. Pharmacol., 57, 729-Xie 735.

    Article  CAS  PubMed  Google Scholar 

  7. Dorado P., Berecz R., Cáceres M.C., LLerena A. (2003): Analysis of diclofenac and its metabolites by high-performance liquid chromatography: Relevance ofCYP2C9 genotypes in diclofenac urinary metabolic ratios. J. Chromatogr B., 789, 437–442.

    Article  CAS  Google Scholar 

  8. Dorado P., Berecz R., Norberto M.J., Yasar Ü., Dahl M.-L., LLerena A. (2003):CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers. Eur. J. Clin. Pharmacol. (in press).

  9. Yasar Ü., Forslund-Bergengren C., Tybring G., et al. (2002): Pharmacokinetics of losartan and its metabolite E-3174 in relation to theCYP2C9 genotype. Clin. Pharmacol. Ther., 71, 89–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Psychiatry, Faculty of Medicine, University of Extremadura, Av. de Elvas s/n., E-06071, Badajoz, Spain

    Pedro Dorado, Roland Berecz, Macarena C. Cáceres, Idilio Conzález & Adrián Llerena

  2. Department of Medical Sciences, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal

    Adrián Llerena

Authors
  1. Pedro Dorado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Berecz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Macarena C. Cáceres
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Idilio Conzález
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adrián Llerena
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dorado, P., Berecz, R., Cáceres, M.C. et al. Reproducibility over time of the urinary diclofenac/4′-OH diclofenac ratio among differentCYP2C9 genotypes. Eur. J. Drug Metab. Pharmacokinet. 28, 213–215 (2003). https://doi.org/10.1007/BF03190487

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190487

Keywords

Search

Navigation